ReNeuron Group
Guildford
About ReNeuron Group
ReNeuron Group engages in the research, development, and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $166.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2015)
- Ticker: lse:RENE
- Website: reneuron.com
- Phone: +44 1483 302560
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/reneuron-group-3660221 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.